GlaxoSmithKline PLC Price to Sales Over Time
GSK Stock | USD 43.13 0.14 0.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out GlaxoSmithKline PLC Performance and GlaxoSmithKline PLC Correlation. GlaxoSmithKline |
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 0.58 | Earnings Share 3.02 | Revenue Per Share 14.97 | Quarterly Revenue Growth 0.092 |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare GlaxoSmithKline PLC ADR and related stocks such as Agilent Technologies, Mustang Bio, and Moleculin Biotech Price to Sales Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | 1.7536 | 1.3061 | 1.8257 | 1.8861 | 3.1139 | 3.3803 | 4.8984 | 4.2323 | 4.6069 | 5.9086 | 7.556 | 6.0407 | 4.4476 | 4.0 | 2.14 |
MBIO | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
MBRX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
CLVRW | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 12.9681 | 7.9441 | 5.1801 | 0.6622 | 0.76 | 0.72 |
MCRB | 18.1239 | 18.1239 | 18.1239 | 18.1239 | 18.1239 | 18.1239 | 18.1239 | 12.7775 | 6.515 | 5.6641 | 58.854 | 5.2708 | 84.909 | 1.4186 | 1.35 |
MDGL | 152 | 29.0624 | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.6 K | 3.3 K | 3.4 K |
EQ | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 2.2686 | 0.6958 | 0.66 |
KA | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 18.0928 | 615 | 7.7064 | 16.0164 | 7.3734 | 7.0 |
ME | 9.0339 | 9.0339 | 9.0339 | 9.0339 | 9.0339 | 9.0339 | 9.0339 | 9.0339 | 9.0339 | 13.0388 | 16.9451 | 5.0926 | 3.4373 | 3.95 | 3.76 |
GlaxoSmithKline PLC ADR and related stocks such as Agilent Technologies, Mustang Bio, and Moleculin Biotech Price To Sales Ratio description
Price to Sales Ratio is figured by comparing GlaxoSmithKline PLC ADR stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on GlaxoSmithKline PLC sales, a figure that is much harder to manipulate than other GlaxoSmithKline PLC ADR multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
GlaxoSmithKline PLC ADR | GSK |
HealthcareFama & French Classification | |
Location | United Kingdom |
Exchange | New York Stock Exchange |
USD 43.13
Check out GlaxoSmithKline PLC Performance and GlaxoSmithKline PLC Correlation. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
CEOs Directory Screen CEOs from public companies around the world |
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.